假腔肋间动脉栓塞阻断慢性B型主动脉夹层R型入口血流
多中心回顾性分析9例慢性B型主动脉夹层伴假腔通畅(7例曾行TEVAR)患者,行假腔肋间动脉弹簧圈栓塞,31支靶血管中30支(97%)成功栓塞,术后全部出现假腔血栓进展,假腔长度均值由13.8 cm降至6.6 cm(降48%),无手术相关死亡及脊髓缺血,2例出现腰大池引流相关并发症。
要点
- 31支靶向假腔肋间动脉中30支(97%)成功弹簧圈栓塞。
- 术后全部患者假腔血栓进展,假腔长度均值由13.8 cm降至6.6 cm(降48%)。
- 无手术相关死亡及脊髓缺血,2例腰大池引流相关并发症经保守处理无神经功能缺损。
核心结论
- 本回顾性分析中,假腔肋间动脉弹簧圈栓塞技术可行,未出现脊髓缺血病例。
- 手术所需操作时间、透视剂量和对比剂用量在可接受范围。
- 全部患者出现假腔血栓进展,未观察到长期手术相关并发症。
- 需要更多数据来确定该手术是否能有效阻断R型入口血流、预防未来II型入口血流并促进主动脉重塑。
研究设计与样本
- 多中心回顾性研究,连续纳入所有假腔肋间动脉栓塞手术,共识别9例。
- 9例均为慢性B型主动脉夹层伴假腔通畅,其中7例曾行胸主动脉腔内修复(TEVAR)。
- 比较术前与术后计算机断层扫描血管造影。
- 作者假设栓塞是安全可行的治疗选择;主要结局为手术特征和脊髓缺血以确立安全性与可行性。
- 次要结局包括腹腔干以上通畅假腔长度变化及其他围手术期临床结局。
主要发现
- 31支靶向假腔肋间动脉中30支(97%)成功弹簧圈栓塞。
- 手术时间中位数57分钟(四分位距[IQR]23-99),空气比释动能中位数585 mGy(IQR 398-1,644),对比剂剂量中位数141 mL(IQR 74-240)。
- 栓塞后全部患者出现假腔血栓进展,假腔长度均值由13.8 cm降至6.6 cm,降低48%。
- 无手术相关死亡;2例发生腰大池引流相关并发症,1例脑脊液漏、1例脊髓血肿,脊髓血肿经保守处理无神经功能缺损。
- 未发生其他并发症。
临床怎么用
- 原文未据此给出推荐,仅报告该栓塞技术可行且未出现脊髓缺血,需更多数据确定其疗效。
局限性
- 需要更多数据来确定该手术是否能有效阻断R型入口血流、预防未来II型入口血流并促进主动脉重塑。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Treatment of aneurysmal type B aortic dissection often involves thoracic endovascular aortic repair (TEVAR). However, persistent patency of the false lumen from type R entry flow is common and is associated with late complications including rupture. We describe 9 patients with aneurysmal chronic type B aortic dissections and patent false lumens and 7 despite prior thoracic endovascular aortic repair. The goal of the false lumen intercostal embolization in these patients was to achieve propagation of false lumen thrombosis (FLT) and to prevent spinal cord ischemia (SCI) using a staged approach in the overall treatment of their complex aortic aneurysm. METHODS: A multicenter retrospective review was performed of all consecutive false lumen intercostal embolization procedures; 9 were identified. Preoperative and postoperative computed tomographic angiograms were compared. We hypothesized that embolization was a safe and feasible treatment option. The primary outcome was procedural characteristics and SCI to establish safety and feasibility. Secondary outcomes included a change in supraceliac patent false lumen length and other perioperative clinical outcomes. RESULTS: In total, 30 of 31 (97%) targeted false lumen intercostal arteries were successfully coiled. Median procedural time was 57 min (interquartile range [IQR] 23-99), median air kerma was 585 mGy (IQR 398-1,644), and median contrast dose was 141 mL (IQR 74-240). After embolization, all patients demonstrated propagation of FLT, with mean false lumen length decreasing by 48% from 13.8 cm to 6.6 cm. There was no mortality associated with this procedure; 2 patients suffered a lumbar drain-related complication; 1 with cerebrospinal fluid leak and 1 with a spinal hematoma that was managed conservatively with no neurological deficit. No other complications occurred. CONCLUSIONS: In this review, false lumen intercostal coil embolization was technically feasible and did not result in any cases of SCI. The procedures required acceptable amounts of operative time, fluoroscopic dose, and contrast. All patients experienced propagation of FLT and no long-term procedure-related morbidity was noted. More data will be required to ascertain whether this procedure is effective at halting type R entry flow, preventing future type II entry flow, and promoting aortic remodeling over time.
引用
- Yi JA, Magee GA, Potter HA, et al. False Lumen Intercostal Artery Embolization to Halt Type R Entry Flow in Chronic Type B Aortic Dissection. Ann Vasc Surg. 2022. PMID: 36055458. doi:10.1016/j.avsg.2022.07.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。